RE:RE:RE:Latest News Release...Back in November, Management suggested a share roll back and investment in another oncology firm as a possibility. Had they gone ahead, and bought say, Oncologic it would have been a smart move and affordable. But they must have believed their own hype and decided to wait for an approval from the FDA.
I had actually suggested purchase of ONC.to back then. It would have a been a slam dunk because ONC is now up to 70 cents (from 40 cents) and TST is down from 70-80 cents to 7 cents.
Our bacon would have been saved instead our scalps have been shaved.